Koji Hasegawa

24PUBLICATIONS
39CO-AUTHORS
Preventative health careAutonomic nervous systemCharacterisation of biological macromoleculesMolecular medicineGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 29, 2026
Lipid-lowering therapy: Evidence and future perspective.

|Nov 21, 2025
Nobiletin Prevents Cardiac Hypertrophy via SIRT5-Mediated Downregulation of p300.

Yoichi Sunagawa, Masafumi Funamoto, Toshihide Hamabe-Horiike

|Jan 08, 2025
Reduction of hypokalaemia with finerenone: a drug or class-specific effect?

Giuseppe M C Rosano, Koh Ono, Egidio Imbalzano

|Oct 30, 2024
Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT2 inhibitors?

Maki Komiyama, Koji Hasegawa, Giuseppe M C Rosano

|Jul 10, 2024
The impact of sodium-glucose cotransporter 2 inhibitors in post-myocardial infarction management: insights from EMPACT-MI and DAPA-MI trials.

Eri Toda Kato, Koji Hasegawa, Koh Ono

|May 02, 2024
Should pharmacotherapy targeting lipoprotein(a) be further expanded for patients with diabetes?

Yihong Sun, Koji Hasegawa, Heinz Drexel

Pageof 4

Frequent Collaborators

3 joint publications

Yasuhiro Hamatani

3 joint publications

Masaharu Akao

2 joint publications

Hisashi Ogawa

2 joint publications

Koh Ono